Abstract
Stent-graft repair of thoracic aortic pathology has progressed to phase II clinical trials of commercially made devices. The latter represent substantial improvements from previously employed homemade constructs. Preliminary experience indicates that stent-graft repair for anatomically suitable degenerative aneurysms will present an effective and less morbid approach when compared to open repair. Prospective trials of stent-graft repair for the other lesions-in-particular acute distal aortic dissections—will be required before its ultimate role is defined.
Keywords
Get full access to this article
View all access options for this article.
